Readystate Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$774K Buy
+2,200
New +$784K 0.03% 354
2025
Q2
Sell
-14,200
Closed -$4.42M 624
2025
Q1
$4.42M Buy
14,200
+9,400
+196% +$2.78M 0.15% 109
2024
Q4
$1.25M Sell
4,800
-46,200
-91% -$13.7M 0.04% 373
2024
Q3
$16.4M Buy
51,000
+48,700
+2,117% +$15.9M 0.31% 81
2024
Q2
$719K Sell
2,300
-31,000
-93% -$9.11M 0.02% 406
2024
Q1
$9.47M Buy
33,300
+31,500
+1,750% +$9.22M 0.13% 200
2023
Q4
$518K Buy
1,800
+500
+38% +$136K 0.02% 457
2023
Q3
$349K Hold
1,300
0.02% 446
2023
Q2
$289K Buy
+1,300
New +$302K 0.02% 248

Other funds holding AMGN

Readystate Asset Management's AMGN Position: Q2 2025 in Review

Readystate Asset Management sold out of Amgen (AMGN) in Q2 2025, closing a stake of 1,519 shares — an estimated $473K sold.

Readystate Asset Management first reported a position in AMGN in Q3 2024 and held it in 3 quarters. The position peaked at $2.19M in Q3 2024. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • Readystate Asset Management reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • Readystate Asset Management sold 1,519 Amgen shares in Q2 2025, an estimated $473K.
  • Readystate Asset Management first reported a position in Amgen in Q3 2024 and held it in 3 quarters.
  • Readystate Asset Management's Amgen position peaked at $2.19M in Q3 2024.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Readystate Asset Management's 13F filing for Q2 2025, filed 7 Aug 2025.